Loading companies…
SB
Sensible Biotechnologies
United Kingdom · Biotech
A platform for designing and manufacturing naturally modified mRNA medicines.
Product
Sensible Biotechnologies combines AI-enabled mRNA design with production of naturally modified mRNA in living cells. Its VECTOR platform is designed to address limitations of conventional synthetic mRNA manufacturing and support a broader range of therapeutic applications. The company is building clinical-grade manufacturing capabilities as it advances the platform.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series A | $47M | Backed VC — ParticipantBlueyard — ParticipantCivilization Ventures — ParticipantIsomer Capital — ParticipantKaya VC — ParticipantOTB Ventures — ParticipantRecode Ventures — ParticipantTech Horizons — ParticipantY Combinator (YC) — Participant |
Investors
Backed VCJoined Series ABlueyardJoined Series ACivilization VenturesJoined Series AIsomer CapitalJoined Series AKaya VCJoined Series AOTB VenturesJoined Series ARecode VenturesJoined Series ATech HorizonsJoined Series AY Combinator (YC)Joined Series ACoverage
Oct 6, 2026Sensible Biotechnologies · Series ASimilar companies
ASAutopoiesis SciencesAutopoiesis Sciences is developing AI research tools that help scientists plan and carry out scientific discovery.$11M · Seed
WGWhiteLab GenomicsWhiteLab Genomics uses AI to design genetic medicines and develop bio-assets for cell, RNA and DNA therapies.$26M · Series B
AnaCardioAnaCardio is a clinical-stage biopharmaceutical company developing medicines intended to improve heart muscle function in people with heart failure.€62.5M · Series B